Send to

Choose Destination
Hematol Oncol Clin North Am. 2005 Aug;19(4):597-609, v.

Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.

Author information

Internal Medicine-Division of Hematology & Oncology, University of Nebraska Medical Center, Lied Transplant Center Room 8715, 987680 Nebraska Medical Center, Omaha, NE 68198-7680, USA.


The diagnosis of lymphoma of the central nervous system (CNS) has been facilitated by advances in neuroimaging and laboratory analysis of cerebrospinal fluid. The most common form of central nervous system CNS involvement in non-Hodgkin's lymphoma (NHL) is leptomeningeal disease. After a diagnosis is established, the use of intrathecal or systemic chemotherapy and radiotherapy can improve survival and palliate symptoms. High-dose systemic chemotherapy with hematopoietic stem cell transplantation is an important treatment option at central nervous system relapse of NHL and for primary CNS lymphoma. The prognosis for disease-free survival and cure is better for patients who have treatment of CNS disease before transplantation than for patients who have active central nervous system disease at the time of transplant.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center